ST 1535

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Product Overview

Product Name	ST 1535
CAS	496955-42-1
Formula	C12H16N8
MW	272.31
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

ST 1535 is a potent and orally active antagonist of A2A adenosine receptor with antiparkinsonian activity and antitremorigenic effects. ST 1535 exhibits the potential for the research of Parkinson’s disease.

Related literature

ST 1535: a preferential A2Aadenosinereceptor antagonist.

PMID: 16867213 DOI: 10.1017/S1461145705006188

Synthesis and biological evaluation of metabolites of 2-n-butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), a potent antagonist of the A2A adenosine receptor for the treatment of Parkinson's disease.

PMID: 23789814 DOI: 10.1021/jm400491x

Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.

PMID: 20665698 DOI: 10.1002/syn.20833

Sorry, no related items

History

CL3064

ST 1535

496955-42-1 98+%

Chemical safety data sheet(MSDS)